Zinc deficiency

Current Opinion in Gastroenterology

Volumn 25, Issue 2, 2009, Pages 136-143

  Tuerk, Melanie J ^a   Fazel, Nasim ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute and chronic liver disease; Diarrheal illness; Immunity; Zinc deficiency

Indexed keywords

TOXIN; ZINC;

ACUTE DIARRHEA; ACUTE DISEASE; ARTICLE; CELL DAMAGE; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HEPATIC ENCEPHALOPATHY; HUMAN; HUMORAL IMMUNITY; INCIDENCE; INFECTION; INTESTINE ABSORPTION; LIVER DISEASE; LIVER INJURY; NONHUMAN; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; OXIDATIVE STRESS; ZINC DEFICIENCY; ZINC METABOLISM;

DEFICIENCY DISEASES; DIETARY SUPPLEMENTS; DYSENTERY; HUMANS; IMMUNITY; INTESTINES; LIVER DISEASES; ZINC;

EID: 64349119523     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328321b395     Document Type: Article

References (149)

1. Raulin J. Chemical studies on vegetation. Annales Des Sci Naturelles 1869; 11:293-299.
2. Todd WR, Elvejheim CA, Hart EB. Zinc in the nutrition of the rat. Am J Physiol 1934; 107:146-156.
3. Drinker K. The significance of zinc in the living organism. J Indust Hygiene 1926; 8:257-269.
4. Wuehler SE, Peerson JM, Brown KH, Use of national food balance data to estimate the adequacy of zinc in national food supplies: methodology and regional estimates. Public Health Nutr 2005; 8:812-819.
5. Prasad AS, Halsted JA, Nadimi M. Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism and geophagia. Am J Med 1961; 31:532-546.
6. Prasad AS, Miale A, Farid Z, et. al. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypognadism. J Lab Clin Med 1963; 61:537-549.
7. Cavdar AO, Arcasoy A, Cin S, et al. Geophagia in turkey: iron and zinc deficiency, iron and zinc absorption studies and response to treatment with zinc in geophagia cases. Prog Clin Biol Res 1983; 129:71-97.
8. Pilch SM, Senti FR. Analysis of zinc data from the second national health and nutrition examination survey (NHANES II). J Nutr 1985; 115:1393-1397.
9. Wakimoto P, Block G. Dietary intake, dietary patterns, and changes with age: an epidemiological perspective. J Gerontol A Biol Sci Med Sci 2001; 56 (Spec No. 2):65-80.
10. Russell R, Beard JL, Cousins RJ, et al. Zinc. In: Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, zinc. Washington, DC: The National Academies Press; 2002. pp. 442-501.
11. Cousins RJ. Metal elements and gene expression. Annu Rev Nutr 1994; 14:449-469.
12. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev 1993; 73:79-118.
13. Maret W. Cellular zinc and redox states converge in the metallothionein/thionein pair. J Nutr 2003; 133 (5 Suppl 1):1460S-1462S.
14. Theocharis SE, Margeli AP, Koutselinis A. Metallothionein: a multifunctional protein from toxicity to cancer. Int J Biol Markers 2003; 18:162-169.
15. Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP. Metallothionein expression in human neoplasia. Histopathology 2004; 45:103-118.
16. Dalton TP, Bittel D, Andrews GK. Reversible activation of mouse metal response element-binding transcription factor 1 DNA binding involves zinc interaction with the zinc finger domain. Mol Cell Biol 1997; 17:2781-2789.
17. Günes C, Heuchel R, Georgiev O, et al. Embryonic lethality and liver degeneration in mice lacking the metal-responsive transcriptional activator MTF-1. EM BO J 1998; 17:2846-2854.
18. Liuzzi JP, Cousins RJ. Mammalian zinc transporters. Annu Rev Nutr 2004; 24:151-172.
19. Liuzzi JP, Blanchard RK, Cousins RJ. Differential regulation of zinc transporter 1, 2, and 4 mrna expression by dietary zinc in rats. J Nutr 2001; 131:46-52.
20. Huang L, Gitschier J. A novel gene involved in zinc transport is deficient in the lethal milk mouse. Nat Genet 1997; 17:292-297.
21. Kelleher SL, Lönnerdal B. Zinc transporters in the rat mammary gland respond to marginal zinc and vitamin A intakes during lactation. J Nutr 2002; 132:3280-3285.
22. Liuzzi JP, Bobo JA, Lichten LA, et al. Responsive transporter genes within the murine intestinal-pancreatic axis form a basis of zinc homeostasis. Proc Natl Acad Sci U S A 2004; 101:14355-14360.
23. Wang F, Kim BE, Dufner-Beattie J, et al. Acrodermatitis enteropathica mutations affect transport activity, localization and zinc-responsive trafficking of the mouse ZIP4 zinc transporter. Hum Mol Genet 2004; 13:563-571.
24. Dufner-Beattie J, Wang F, Kuo YM, et al. The acrodermatitis enteropathica gene ZIP4 encodes a tissue-specific, zinc-regulated zinc transporter in mice. J Biol Chem 2003; 278:33474-33481.
25. Dufner-Beattie J, Kuo YM, Gitschier J, Andrews GK. The adaptive response to dietary zinc in mice involves the differential cellular localization and zinc regulation of the zinc transporters ZIP4 and ZIP5. J Biol Chem 2004; 279:49082-49090.
26. Kim BE, Wang F, Dufner-Beattie J,et. al.Zn2+-stimulated endocytosis of the mzip4 zinc transporter regulates its location at the plasma membrane. J Biol Chem 2004; 279:4523-4530.
27. Wang K, Zhou B, Kuo YM, et. al. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet 2002; 71:66-73.
28. Cousins RJ. Theoretical and practical aspects of zinc uptake and absorption. Adv Exp Med Biol 1989; 249:3-12.
29. Lee HH, Prasad AS, Brewer GJ, Owyang C. Zinc absorption in human small intestine. Am J Physiol 1989; 256 (1 Pt 1):G87-91.
30. Lonnerdal B. Intestinal absorption of zinc. In: Mills CF, editor. Zinc in human biology. New York: Springer-Verlag; 1989. pp. 33-55.
31. Baer MT, King JC. Tissue zinc levels and zinc excretion during experimental zinc depletion in young men. Am J Clin Nutr 1984; 39:556-570.
32. Jackson MJ, Jones DA, Edwards RH, et. al. Zinc homeostasis in man: studies using a new stable isotope-dilution technique. Br J Nutr 1984; 51:199-208.
33. Steel L, Cousins RJ. Kinetics of zinc absorption by luminally and vascularly perfused rat intestine. Am J Physiol 1985; 248 (1 Pt 1):G46-G53.
34. Taylor CM, Bacon JR, Aggett PJ, Bremner I. Homeostatic regulation of zinc absorption and endogenous losses in zinc-deprived men. Am J Clin Nutr 1991; 53:755-763.
35. King JC, Shames DM, Woodhouse LR. Zinc homeostasis in humans. J Nutr 2000; 130 (Suppl 5S):1360S-1366S.
36. Sandstrom B, Lonnerdal B. Promoters and antagonists of zinc absorption. In: Mills CF, editor. Zinc in human biology. New York: Springer-Verlag; 1989 pp. 57-78.
37. Roth HP, Kirchgessner M. Utilization of zinc from picolinic or citric acid complexes in relation to dietary protein source in rats. J Nutr 1985; 115:1641-1649.
38. King JC, Keen CL. Zinc. In: Shils ME, Olson JA, Shike M, Ross AC, editors. Modern nutrition in health and disease. Baltimore: Williams & Wilkins; 1999 pp. 223-239.
39. Fischer Walker CL, Ezzati M, Black RE. Global and regional child mortality and burden of disease attributable to zinc deficiency. Eur J Clin Nutr 2008. http://dx.doi.0rg/10.1038/ejcn.2008.9 [Epub ahead of print].
40. Prasad AS, Meftah S, Abdallah J, et. al. Serum thymulin in human zinc deficiency. J Clin Invest 1988; 82:1202-1210.
41. Beck FW, Prasad AS, Kaplan J, et. al. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 1997; 272 (6 Pt 1):E1002-E1007.
42. Beck FW, Kaplan J, Fine N, et. al. Decreased expression of CD73 (ecto-5'-nucleotidase) in the CD8+ subset is associated with zinc deficiency in human patients. J Lab Clin Med 1997; 130:147-156.
43. Prasad AS. Zinc: mechanisms of host defense. J Nutr 2007; 137:1345-1349.
44. Rink L, Haase H. Zinc homeostasis and immunity. Trends Immunol 2007; 28:1-4.
45. Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr 2004; 24:277-298.
46. Overbeck S, Rink L, Haase H. Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases. Arch Immunol Ther Exp (Warsz) 2008; 56:15-30.
47. lbs KH, Rink L. Zinc-altered immune function. J Nutr 2003; 133 (5 Suppl 1):1452S-1456S.
48. Rink L, Gabriel P. Extracellular and immunological actions of zinc. Biometals 2001; 14:367-383.
49. Metz CH, Schröder AK, Overbeck S, et. al. T-helper type 1 cytokine release is enhanced by in vitro zinc supplementation due to increased natural killer cells. Nutrition 2007; 23:157-163.
50. Long KZ, Rosado JL, Montoya Y, et. al. Effect of vitamin A and zinc supplementation on gastrointestinal parasitic infections among mexican children. Pediatrics 2007; 120:e846-e855.
51. Prasad AS, Beck FW, Bao B, et. al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 2007; 85:837-844.
52. Cuevas LE, Koyanagi A. Zinc and infection: a review. Ann Trop Paediatr 2005; 25:149-160.
53. Sazawal S, Black RE, Jalla S, et. al. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial. Pediatrics 1998; 102 (1 Pt 1):1-5.
54. Brooks WA, Yunus M, Santosham M, et. al. Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. Lancet 2004; 363:1683-1688.
55. Brooks WA, Santosham M, Naheed A, et. al. Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial. Lancet 2005; 366:999-1004.
56. Sandstead HH. Understanding zinc: recent observations and interpretations. J Lab Clin Med 1994; 124:322-327.
57. Prasad AS, Fitzgerald JT, Hess JW, et. al. Zinc deficiency in elderly patients. Nutrition 1993; 9:218-224.
58. Garfinkel D. Is aging inevitable? The intracellular zinc deficiency hypothesis of aging. Med Hypotheses 1986; 19:117-137.
59. Ozaki Y, Ohashi T, Kume S. Potentiation of neutrophil function by recombinant dna-produced interleukin 1a. J Leukoc Biol 1987; 42:621-627.
60. Berkow RL, Wang D, Larrick JW, et. al. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J Immunol 1987; 139:3783-3791.
61. Powell SR. The antioxidant properties of zinc. J Nutr 2000; 130 (Suppl 5S): 1447S-1454S.
62. DiSilvestro RA. Zinc in relation to diabetes and oxidative disease. J Nutr 2000; 130 (Suppl 5S):1509S-1511S.
63. Parsons SE, DiSilvestro RA. Effects of mild zinc deficiency, plus or minus an acute-phase response, on galactosamine-induced hepatitis in rats. Br J Nutr 1994; 72:611-618.
64. Chvapil M, Elias SL, Ryan JN, Zukoski CF. Pathophysiology of zinc. In: Internatipnal review of neurobiology. New York: Academy Press; 1972. pp. 105-124.
65. Bray TM, Bettger WJ. The physiological role of zinc as an antioxidant. Free Radio Biol Med 1990; 8:281-291.
66. Prasad AS, Bao B, Beck FW, et. al. Antioxidant effect of zinc in humans. Free Radio Biol Med 2004; 37:1182-1190.
67. Stehbehs WE. Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc. Exp Mol Pathol 2003; 75:265-276.
68. Palmiter RD, Cole TB, Findley SD. Znt-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO J 1996; 15:1784-1791.
69. Stamouiis I, Kouraklis G, Theocharis S. Zinc and the liver: an active interaction. Dig Dis Sci 2007; 52:1595-1612.
70. Prasad AS, Kucuk O. Zinc in cancer prevention. Cancer Metastasis Rev 2002; 21:291-295.
71. Mocchegiani E, Bertoni-Freddari C, Marcellini F, Malavolta M. Brain, aging and neurodegeneration: role of zinc ion availability. Prog Neurobiol 2005; 75:367-390.
72. Cakman I, Kirchner H, Rink L. Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. J Interferon Cytokine Res 1997; 17:469-472.
73. Prasad AS, editor. Biochemistry of zinc. New York: Plenum; 1993.
74. Krebs NE, Hambidge KM. Zinc metabolism and homeostasis: the application of tracer techniques to human zinc physiology. Biometals 2001; 14:397-412.
75. Grungreiff K. Zinc in liver disease. J Trace Elem Exp Med 2002; 15:67-78.
76. Fota-Markowska H, Przybyta A, Borowicz I, Modrzewska R. Serum zinc (zn) level dynamics in blood serum of patients with acute viral hepatitis B and early recovery period. Ann Univ Mariae Curie Sklodowska [Med] 2002; 57:201-209.
77. Kalkan A, Bulut V, Avci S, et. al. Trace elements in viral hepatitis. J Trace Elem Med Biol 2002; 16:227-230.
78. Bode JC, Hanisch P, Henning H, et al. Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis. Hepatology 1988; 8:1605-1609.
79. Kiilerich S, Dietrichson O, Loud FB, et. al. Zinc depletion in alcoholic liver diseases. Scand J Gastroenterol 1980; 15:363-367.
80. Polavarapu R, Spitz DR, Sim JE, et. al. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 1998; 27:1317-1323.
81. Zhou Z, Sun X, Lambert JC, et. al. Metallothionein-independent zinc protection from alcoholic liver injury. Am J Pathol 2002; 160:2267-2274.
82. Chetri K, Choudhuri G. Role of trace elements in hepatic encephalopathy: zinc and manganese. Indian J Gastroenterol 2003; 22 (Suppl 2):S28-S30.
83. Loomba V, Pawar G, Dhar KL, Setia MS. Serum zinc levels in hepatic encephalopathy. Indian J Gastroenterol 1995; 14:51-53.
84. DiSilvestro RA, Carlson GP. Effects of mild zinc deficiency, plus or minus acute phase response, on ccl4 hepatotoxicity. Free Radic Biol Med 1994; 16:57-61.
85. Cagen SZ, Klaassen CD. Protection of carbon tetrachloride-induced hepatotoxicity by zinc: role of metallothionein. Toxicol Appl Pharmacol 1979; 51:107-116.
86. Cagen SZ, Klaasen CD. Carbon tetrachloride-induced hepatotoxicity: studies in developing rats and protection by zinc. Fed Proc 1980; 39:3124-3128.
87. Ademuyiwa O, Onitilo O, Dosumu O, et al. Zinc in ccl4 toxicity. Biomed Environ Sci 2002; 15:187-195.
88. Itoh N, Kimura T, Nakanishi H, et al. Metallothionein-independent hepato protection by zinc and sakuraso-saponin. Toxicol Lett 1997; 93:135-140.
89. Davis SR, Samuelson DA, Cousins RJ. Metallothionein expression protects against carbon tetrachloride-induced hepatotoxicity, but overexpression and dietary zinc supplementation provide no further protection in metallothionein transgenic and knockout mice. J Nutr 2001; 131:215-222.
90. Srinivasan S, Balwani JH. Effect of zinc sulphate on carbon tetrachloride hepatotoxicity. Acta Pharmacol Toxicol (Copenh) 1969; 27:424-428.
91. Poo JL, Rosas-Romero R, Rodriguez F, et al. Serum zinc concentrations in two cohorts of 153 healthy subjects and 100 cirrhotic patients from Mexico City. Dig Dis 1995; 13:136-142.
92. Pramoolsinsap C, Promvanit N, Komindr S, et al. Serum trace metals in chronic viral hepatitis and hepatocellular carcinoma in Thailand. J Gastroenterol 1994; 29:610-615.
93. Prasad AS. Clinical and biochemical manifestation zinc deficiency in human subjects. J Pharmacol 1985; 16:344-352.
94. Barry M, Keeling PW, Feely J. Tissue zinc status and drug elimination in patients with chronic liver disease. Clin Sci (Lond) 1990; 78:547-549.
95. Cabré M, Camps J, Paternáin JL, et a/. Time-course of changes in hepatic lipid peroxidation and glutathione metabolism in rats with carbon tetrachloride induced cirrhosis. Clin Exp Pharmacol Physiol 2000; 27:694-699.
96. Madden AM, Bradbury W, Morgan MY. Taste perception in cirrhosis: its relationship to circulating micronutrients and food preferences. Hepatology 1997; 26:40-48.
97. Solis-Herruzo J, De Cuenca B, Mun̄oz-Rivero MC. Intestinal zinc absorption in cirrhotic patients. Z Gastroenterol 1989; 27:335-338.
98. Sartori M, Calgaro M, Campanini M, et al. Determination of zinc and copper in patients with liver cirrhosis of diverse clinical severity. Minerva Med 1988; 79:891-895.
99. Göksu N, Ozsoylu S. Hepatic and serum levels of zinc, copper, and magnesium in childhood cirrhosis. J Pediatr Gastroenterol Nutr 1986; 5:459-462.
100. Gaveau D, Piette F, Cortot A, et al. Cutaneous manifestations of zinc deficiency in ethylic cirrhosis. Ann Dermatol Venereol 1987; 114:39-53.
101. Rocchi E, Borella P, Borghi A, et al. Zinc and magnesium in liver cirrhosis. Eur J Clin Invest 1994; 24:149-155.
102. Gür G, Bayraktar Y, Ozer D, et al. Determination of hepatic zinc content in chronic liver disease due to hepatitis B virus. Hepatogastroenterology 1998; 45:472-476.
103. Goode HF, Kelleher J, Walker BE. Relation between zinc status and hepatic functional reserve in patients with liver disease. Gut 1990; 31:694-697.
104. Gil Extremera B, Maldonado Martin A, Ruiz Martinez M, et al. Zinc and liver cirrhosis. Acta Gastroenterol Belg 1990; 53:292-298.
105. ljuin H. Evaluation of pancreatic exocrine function and zinc absorption in alcoholism. Kurume Med J 1998; 45:1-5.
106. Schlienger JL, Willemin B, Lang JM, et al. Evaluation of malnutrition and immunity in alcoholic liver diseases. Presse Med 1986; 15:1023-1027.
107. Bro S, Stokholm M, Jergensen PJ. Zinc in mononuclear leucocytes in alcoholics with liver cirrhosis or chronic pancreatitis and in patients with Crohn's disease before and after zinc supplementation. J Trace Elem Electrolytes Health Dis 1989; 3:243-248.
108. Aaseth J, Smith-Kielland A, Thomassen Y. Selenium, alcohol and liver diseases. Ann Clin Res 1986; 18:43-47.
109. Vallee BL, Wacker WE, Bartholomay AF, Hoch FL. Zinc metabolism in hepatic dysfunction. II. Correlation of metabolic patterns with biochemical findings. N Engl J Med 1957; 257:1055-1065.
110. Chapman KM, Prabhudesai M, Erdman JW. Vitamin A status of alcoholics upon admission and after two weeks of hospitalization. J Am Coll Nutr 1993; 12:77-83.
111. Grüngreiff K, Abicht K, Kluge M, et al. Clinical studies on zinc in chronic liver diseases. Z Gastroenterol 1988; 26:409-415.
112. Yang SS, Lai YC, Chiang TR, et. al. Role of zinc in subclinical hepatic encephalopathy: comparison with somatosensory-evoked potentials. J Gastroenterol Hepatol 2004; 19:375-379.
113. Romero-Gómez M, Boza F, Garcia-Valdecasas MS, et. al. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96:2718-2723.
114. Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet 1984; 2:493-495.
115. Riggio O, Ariosto F, Merli M, et. al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci 1991; 36:1204-1208.
116. Bresci G, Parisi G, Banti S. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment. Eur J Med 1993; 2:414-416.
117. Blei AT, Córdoba J, Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol 2001; 96:1968-1976.
118. Quero Guillén JC, Carmona Soria I, Garcia Montes JM, et. al. Hepatic encephalopathy: nomenclature, pathogenesis and treatment. Rev Esp En ferm Dig 2003; 95:135-142; 127-134.
119. Karayalcin S, Arcasoy A, Uzunalimoglu O. Zinc plasma levels after oral zinc tolerance test in nonalcoholic cirrhosis. Dig Dis Sci 1988; 33:1096-1102.
120. Milman N, Hvid-Jacobsen K, Hegnhoøj J, Soørensen SS. Zinc absorption in patients with compensated alcoholic cirrhosis. Scand J Gastroenterol 1983; 18:871-875.
121. Yoshida Y, Higashi T, Nouso K, et. al. Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis. Acta Med Okayama 2001; 55:349-355.
122. Atukorala TM, Herath CA, Ramachandran S. Zinc and vitamin A status of alcoholics in a medical unit in Sri Lanka. Alcohol Alcohol 1986; 21:269-275.
123. Kahn AM, Ozeran MD. Liver and serum zinc abnormalities in rats with cirrhosis. Gastroenterology 1967; 53:193-197.
124. Pöschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol 2004; 39:155-165.
125. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet 2003; 361:2226-2234.
126. Kosek M, Bern C, Guerrant RL The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003; 81:197-204.
127. Roy SL, Scallan E, Beach MJ. The rate of acute gastrointestinal illness in developed countries. J Water Health 2006; 4 (Suppl 2):31-69.
128. Bahl R, Bhandari N, Hambidge KM, Bhan MK. Plasma zinc as a predictor of diarrheal and respiratory morbidity in children in an urban slum setting. Am J Clin Nutr 1998; 68 (Suppl 2):414S-417S.
129. Koo SI, Turk DE. Effect of zinc deficiency on the ultrastructure of the pancreatic acinar cell and intestinal epithelium in the rat. J Nutr 1977; 107:896-908.
130. Roy SK, Tomkins AM. Impact of experimental zinc deficiency on growth, morbidity and ultrastructural development of intestinal tissue. Bangladesh J Nutr 1989; 2:1-7.
131. Bhatnagar S, Bahl R, Sharma PK, et. al. Zinc with oral rehydration therapy reduces stool output and duration of diarrhea in hospitalized children: a randomized controlled trial. J Pediatr Gastroenterol Nutr 2004; 38:34-40.
132. Bhatnagar S, Sharma P, Bahl R, et. al. Zinc supplementation as an adjunct to ORT in children with non cholera diarrhea. Proceedings of the 9th Asian conference on diarrheal diseases and nutrition; 28-30 September 2001; New Delhi, India; 2001. p. 30.
133. Dutta P, Mitra U, Datta A, et. al. Impact of zinc supplementation in malnourished children with acute watery diarrhoea. J Trap Pediatr 2000; 46:259-263.
134. Bhan MK. Current concepts in management of acute diarrhea. Indian Pediatr 2003; 40:463-476.
135. Lukacik M, Thomas RL, Aranda JV. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. Pediatrics 2008; 121:326-336.
136. Bettger WJ, O'Dell BL. A critical physiological role of zinc in the structure and function of biomembranes. Life Sci 1981; 28:1425-1438.
137. Gebhard RL, Karouani R, Prigge WF, McClain CJ. The effect of severe zinc deficiency on activity of intestinal disaccharidases and 3-hydroxy-3- methylglutaryl coenzyme A reductase in the rat. J Nutr 1983; 113:855-859.
138. Fenwick PK, Aggett PJ, Macdonald DC, et al. Zinc deprivation and zinc repletion: effect on the response of rats to infection with strongyloides ratti. Am J Clin Nutr 1990; 52:173-177.
139. Walker CF, Black RE. Zinc and the risk for infectious disease. Annu Rev Nutr 2004; 24:255-275.
140. Fosmire GJ. Zinc toxicity. Am J Clin Nutr 1990; 51:225-227.
141. Prasad AS, Brewer GJ, Schoomaker EB, Rabbani P. Hypocupremia induced by zinc therapy in adults. JAMA 1978; 240:2166-2168.
142. Porter KG, McMaster D, Elmes ME, Love AH. Anaemia and low serum copper during zinc therapy. Lancet 1977; 2:774.
143. Maverakis E, Fung MA, Lynch PJ, et. al. Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol 2007; 56:116-124.
144. Scrimgeour AG, Lukaski HC. Zinc and diarrheal disease: current status and future perspectives. Curr Opin Clin Nutr Metab Care 2008; 11:711-717.
145. Heyland DK, Jones N, Cvijanovich NZ, Wong H. Zinc supplementation in critically ill patients: a key pharmaconutrient? JPEN J Parenter Enteral Nutr 2008; 32:509-519.
146. Matarese LE, Steiger E, Seidner DL Review of a potential role for zinc supplementation in oral rehydration solutions. Nutr Clin Pract 2003; 18:240-246.
147. Sundaram A, Koutkia P, Apovian CM. Nutritional management of short bowel syndrome in adults. J Clin Gastroenterol 2002; 34:207-220.
148. Murakami M, Hirano T. Intracellular zinc homeostasis and zinc signaling. Cancer Sci 2008; 99:1515-1522.
149. Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med 2008; 14:353-357.